Non-alcoholic fatty liver disease in children | OM #2.2
Learning Objectives:
By the end of this session, participants will be able to:
- Appreciate the many comorbidities seen in children with NAFLD and its relevance to your
practice - Understand the recommendations for treatment of NAFLD in Children from the Expert
Committee on NAFLD (ECON) and the North American Society of Pediatric
Gastroenterology, Hepatology and Nutrition (NASPGHAN)
Vicky Le Ng, MD, FRCP (C), Staff Hepatologist at the Hospital for Sick Children
Dr. Vicky Lee Ng is a Professor of Pediatrics at the University of Toronto, staff hepatologist in the Division of Pediatric Gastroenterology, Hepatology and Nutrition, and Medical Director of the Liver Transplant Program at The Hospital for Sick Children.
Resources Mentioned in Session
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- NAFLD: a multisystem disease
- The Pharmacological Management of NAFLD in Children and Adolescents
- Virtual Reality: New Insights Regarding the Prevalence of Nonalcoholic Fatty Liver Disease in Children and Adolescents with Obesity Using Magnetic Resonance Imaging
- NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)
- Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children
- NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children
- A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD
Session Materials
You must be logged in to view this content.